Yale researchers have identified factors that may contribute to widening cancer death disparities among counties across the United States. These factors, which include both socioeconomic and behavioral traits, may provide public health experts with specific targets for potentially reducing cancer disparities, the researchers said.
The highest priority in a national cancer control plan must be expansion of tobacco control—the intervention with the largest potential health benefits—according to a new American Cancer Society report, the second in a series of articles that together inform priorities for a comprehensive cancer control plan.
Study shows DNA biomarker can be used to predict outcomes for high risk low grade gliomas
Steven Artandi, professor of medicine and of biochemistry at the School of Medicine, was named director of the Stanford Cancer Institute effective Oct. 1.
Allan Tsung was appointed director of the Division of Surgical Oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the Ohio State University College of Medicine.
Marc Hurlbert was named chief science officer at the Melanoma Research Alliance. He will begin his role Nov. 1, 2018.
Rachel Katzenellenbogen was named the inaugural Chuck and Tina Pagano Scholar at Indiana University School of Medicine. She will hold that title as well as associate professor of pediatrics.
How do you begin a quest to cure 60 percent of children with six common types of childhood cancer worldwide by 2030?
The $15 million collaboration between St. Jude Children's Research Hospital and the World Health Organization is the first step to improving access in low and middle-income countries to affordable treatments for six common types of childhood cancer, said James Downing, St. Jude president and CEO.
